151 related articles for article (PubMed ID: 8656251)
1. Palliative effect of metaiodobenzylguanidine in metastatic carcinoid tumors.
Taal BG; Hoefnagel CA; Valdes Olmos RA; Boot H; Beijnen JH
J Clin Oncol; 1996 Jun; 14(6):1829-38. PubMed ID: 8656251
[TBL] [Abstract][Full Text] [Related]
2. Results of [131I]metaiodobenzylguanidine treatment in metastatic carcinoid.
Bestagno M; Pizzocaro C; Pagliaini R; Rossini PL; Guerra P
J Nucl Biol Med (1991); 1991; 35(4):343-5. PubMed ID: 1823854
[TBL] [Abstract][Full Text] [Related]
3. Acute liver necrosis induced by iodine-131-MIBG in the treatment of metastatic carcinoid tumors.
Bongers V; de Klerk JM; Zonnenberg BA; de Kort G; Lips CJ; van Rijk PP
J Nucl Med; 1997 Jul; 38(7):1024-6. PubMed ID: 9225784
[TBL] [Abstract][Full Text] [Related]
4. Role of [131I]metaiodobenzylguanidine therapy in carcinoids.
Hoefnagel CA; Taal BG; Valdés Olmos RA
J Nucl Biol Med (1991); 1991; 35(4):346-8. PubMed ID: 1726678
[TBL] [Abstract][Full Text] [Related]
5. Preliminary results of [131I]metaiodobenzylguanidine treatment in metastatic carcinoid tumors.
Colombo L; Vignati A; Lomuscio G; Dottorini ME
J Nucl Biol Med (1991); 1991; 35(4):352-4. PubMed ID: 1823856
[TBL] [Abstract][Full Text] [Related]
6. Iodine-131 metaiodobenzylguanidine treatment for metastatic carcinoid. Results in 98 patients.
Safford SD; Coleman RE; Gockerman JP; Moore J; Feldman J; Onaitis MW; Tyler DS; Olson JA
Cancer; 2004 Nov; 101(9):1987-93. PubMed ID: 15455358
[TBL] [Abstract][Full Text] [Related]
7. Long-term palliation in metastatic carcinoid tumours with various applications of meta-iodobenzylguanidin (MIBG): pharmacological MIBG, 131I-labelled MIBG and the combination.
Zuetenhorst H; Taal BG; Boot H; Valdes Olmos R; Hoefnagel C
Eur J Gastroenterol Hepatol; 1999 Oct; 11(10):1157-64. PubMed ID: 10524647
[TBL] [Abstract][Full Text] [Related]
8. Improved effect of 131I-MIBG treatment by predosing with non-radiolabeled MIBG in carcinoid patients, and studies in xenografted mice.
Taal BG; Hoefnagel C; Boot H; Valdés Olmos R; Rutgers M
Ann Oncol; 2000 Nov; 11(11):1437-43. PubMed ID: 11142484
[TBL] [Abstract][Full Text] [Related]
9. Iodine-131-MIBG therapy of a patient with carcinoid liver metastases.
Prvulovich EM; Stein RC; Bomanji JB; Ledermann JA; Taylor I; Ell PJ
J Nucl Med; 1998 Oct; 39(10):1743-5. PubMed ID: 9776280
[TBL] [Abstract][Full Text] [Related]
10. Combined diagnostic imaging with 131I-metaiodobenzylguanidine and 111In-pentetreotide in carcinoid tumours.
Taal BG; Hoefnagel CA; Valdés Olmos RA; Boot H
Eur J Cancer; 1996 Oct; 32A(11):1924-32. PubMed ID: 8943676
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome and toxicity after dose-intensified treatment with 131I-MIBG for advanced metastatic carcinoid tumors.
Ezziddin S; Sabet A; Logvinski T; Alkawaldeh K; Yong-Hing CJ; Ahmadzadehfar H; Grünwald F; Biersack HJ
J Nucl Med; 2013 Dec; 54(12):2032-8. PubMed ID: 24101685
[TBL] [Abstract][Full Text] [Related]
12. (131)I-MIBG radionuclide therapy is safe and cost-effective in the control of symptoms of the carcinoid syndrome.
Pathirana AA; Vinjamuri S; Byrne C; Ghaneh P; Vora J; Poston GJ
Eur J Surg Oncol; 2001 Jun; 27(4):404-8. PubMed ID: 11417988
[TBL] [Abstract][Full Text] [Related]
13. 131I-metaiodobenzylguanidine therapy for malignant pheochromocytoma.
Sakahara H; Endo K; Saga T; Hosono M; Kobayashi H; Konishi J
Ann Nucl Med; 1994 May; 8(2):133-7. PubMed ID: 7521194
[TBL] [Abstract][Full Text] [Related]
14. [Carcinoid tumor metastases visualized by I-MIBG. Report of 5 cases].
Mey P; Minier JF
Ann Radiol (Paris); 1990; 33(4-5):237-9. PubMed ID: 2268126
[No Abstract] [Full Text] [Related]
15. Iodine-131 metaiodobenzylguanidine scintigraphy of carcinoid tumors.
Feldman JM; Blinder RA; Lucas KJ; Coleman RE
J Nucl Med; 1986 Nov; 27(11):1691-6. PubMed ID: 3772504
[TBL] [Abstract][Full Text] [Related]
16. [Role of 131I-metaiodobenzylguanidine scintigraphy in the diagnosis of intestinal carcinoids].
Bihl H; Sautter-Bihl ML; Wilhelm KR; Kimmig B
Nuklearmedizin; 1987 Dec; 26(6):263-7. PubMed ID: 3438170
[TBL] [Abstract][Full Text] [Related]
17. Treatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumours with 131I-metaiodobenzylguanidine.
Bomanji J; Britton KE; Ur E; Hawkins L; Grossman AB; Besser GM
Nucl Med Commun; 1993 Oct; 14(10):856-61. PubMed ID: 8233228
[TBL] [Abstract][Full Text] [Related]
18. [131I]metaiodobenzylguanidine therapy in carcinoid tumors.
Castellani MR; Di Bartolomeo M; Maffioli L; Zilembo N; Gasparini M; Buraggi GL
J Nucl Biol Med (1991); 1991; 35(4):349-51. PubMed ID: 1823855
[TBL] [Abstract][Full Text] [Related]
19. 131I-meta-iodobenzylguanidine in the management of metastatic midgut carcinoid tumors.
Sywak MS; Pasieka JL; McEwan A; Kline G; Rorstad O
World J Surg; 2004 Nov; 28(11):1157-62. PubMed ID: 15490060
[TBL] [Abstract][Full Text] [Related]
20. The role of I-131-MIBG in the diagnosis and therapy of carcinoids.
Hoefnagel CA; den Hartog Jager FC; Taal BG; Abeling NG; Engelsman EE
Eur J Nucl Med; 1987; 13(4):187-91. PubMed ID: 2441993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]